A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/1999
10/13/1999	EP0948352A1 Chlamydia vaccines
10/13/1999	EP0948350A1 Mycobacterium cell wall compositions
10/13/1999	EP0948348A1 Manipulation of non-terminally differentiated cells using the notch pathway
10/13/1999	EP0948342A1 MEDICAL USES OF scuPA/suPAR COMPLEX
10/13/1999	EP0948319A2 Encapsulated cells producing antibodies
10/13/1999	EP0948256A1 Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral rna
10/13/1999	EP0658111B1 Methods for enhancing drug delivery with modified saponins
10/13/1999	EP0618968B1 Tools for the diagnosis and treatment of alzheimer's disease
10/13/1999	EP0564592B1 Liver enriched transcription factor
10/13/1999	EP0489153B1 Vaccine compositions containing liposomes
10/13/1999	CN1231614A Method of producing active immunity with vaccine conjugate
10/13/1999	CN1231613A Vaccine composition against malaria
10/13/1999	CN1231601A Oral delayed immediate release formulation and method of preparation therefor
10/13/1999	CN1045621C Process for preparing immunoglobulin conjugates
10/12/1999	US5965726 Method of eliminating inhibitory/ instability regions of mRNA
10/12/1999	US5965714 Method for the covalent attachment of polysaccharides to protein molecules
10/12/1999	US5965711 A protein; anticarcinogenic/antiarthritic/antidiabetic agents; treatment of addison's and crohn's disease, multiple sclerosis, scleroderma, ulcers, respiratory disorders; fungicides, viricides, bactericides
10/12/1999	US5965710 An immunoglobulin which binds human membrane-bound carcinoembryonic antigen; anticarcinogenic agent
10/12/1999	US5965535 Isolated human leukocyte antigen (hla) class ii-binding peptide and amino sequence encoding it; the peptides stimulate the activity and proliferation of cd4+ t lymphocytes
10/12/1999	US5965532 Low molecular weight, synthetic crosslinking boron compounds as an agonists or antagonists and induce association between naturally occurring receptors, t cell surface receptor
10/12/1999	US5965521 Pulsatile delivery of leptin receptor ligands
10/12/1999	US5965455 Ryegrass pollen allergen
10/12/1999	US5965435 Genetically engineered genes containing the herpes virus of turkeys gc gene, thymidine kinase region of marek's disease virus, infectious laryngotracheitis virus's open reading frame and ribonucleotide reductase genes; for vaccines
10/12/1999	US5965420 A protein which stimulates cell proliferation; treatment of bone loss due to osteoporosis; treat adult respiratory disease syndrome, parkinson'disease, huntington's disease; antiarthritic/anticarcinogenic agents; antiallergens
10/12/1999	US5965416 Arginyl tRNA synthetase from staphyloccus aureus
10/12/1999	US5965402 DNA encoding phoH polypeptides
10/12/1999	US5965400 DNA encoding a truncated pneumogoccal surface protein (PspA)
10/12/1999	US5965390 Protein L and hybrid proteins thereof
10/12/1999	US5965382 Nucleic acid encoding secreted Mac-2 binding glycoprotein
10/12/1999	US5965381 A mutant strain deficient in producing functional effector proteins; used for heterologous protein transfer into antigen presenting cells; treating infections by pathogens; inducing cellular immune response
10/12/1999	US5965360 Diagnosis of metastatic cancer by the mts-1 gene
10/12/1999	US5965353 An epitope; for a diagnostic kit
10/12/1999	US5965144 Chitosan induced immunopotentiation
10/12/1999	US5965143 Leishania gene encoding histone polypeptide haveing protective capacity against leishmaniasis
10/12/1999	US5965142 Polypeptides and methods for the detection of L. tropica infection
10/12/1999	US5965141 Epitopic regions of pneumococcal surface protein a
10/12/1999	US5965140 Hybrid particle immunogens
10/12/1999	US5965139 Chicken infectious anemia virus vaccine
10/12/1999	US5965138 Recombinant chimeric virus and vaccine comprising a long viral genomic region from the herpes virus of turkeys and a short viral genomic region from marek's disease virus; immunizing birds
10/12/1999	US5965136 Bone resorption assay
10/12/1999	US5965135 HIV-1 virus isolates of a subtype and its differential diagnostics
10/12/1999	US5965134 Immunogenic composition against Classical Swine Fever Virus (CSFV)
10/12/1999	US5965133 Self-assembling multimeric nucleic acid constructs
10/12/1999	US5965131 Galactosylated clearing agent binds to the primary binding site of the primary targeting species, and only non-bound primary targeting species is cleared, not bound species second site is not blocked by the clearing agent
10/12/1999	US5965130 Inhibiting metastasis of a tumor in a mammal by administering intravenous immunoglobulin (inig) in a specific dosage either as a sole agent or in combination with other agent used in cancer treatment
10/12/1999	US5965125 Hybrid matrix implants and explants
10/12/1999	US5965124 Replication-competent recombinant viral vaccines and method of producing same
10/12/1999	US5965121 Compounds and compositions for delivering active agents
10/12/1999	CA1340781C Tumor specific monoclonal antibodies
10/07/1999	WO1999050461A1 Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis
10/07/1999	WO1999050424A2 Fusion protein comprising a sequence from a major coat protein of a papovavirus
10/07/1999	WO1999050419A2 A method for generating nonpathogenic, infectious pancreatic necrosis virus (ipnv) from synthetic rna transcripts
10/07/1999	WO1999050418A1 Treatment and diagnosis of staphylococcal infections
10/07/1999	WO1999050394A1 Suppressive monocyte derived cells, process for their preparation and their uses in pharmaceutical compositions
10/07/1999	WO1999050392A1 Methods and compositions for eliciting an immune response to a telomerase antigen
10/07/1999	WO1999050391A1 Stimulated monocyte derived cells, their preparation and uses
10/07/1999	WO1999050387A1 Vaccination modalities
10/07/1999	WO1999050297A1 Nk cell activation inducing ligand (nail) dna and polypeptides, and use thereof
10/07/1999	WO1999050292A1 Recombinant virus
10/07/1999	WO1999050285A2 Production methods and uses of a retrovirus
10/07/1999	WO1999050279A1 Antisense compositions for detecting and inhibiting telomerase reverse transcriptase
10/07/1999	WO1999049898A1 Progression elevated gene-3 and uses thereof
10/07/1999	WO1999049894A1 Antagonists to growth arrest specific gene 6 to treat insulin-resistant disorders
10/07/1999	WO1999049893A1 Methods for designing molecular conjugates and compositions thereof
10/07/1999	WO1999049892A2 Use of active p40 conjugates for nasal delivery
10/07/1999	WO1999049890A1 A preventive and therapeutic vaccine for helicobacter pylori-associated diseases
10/07/1999	WO1999049888A2 Identification of bacterial avirulence genes and their products; vaccines and pharmaceutical compositions containing them
10/07/1999	WO1999049880A1 Methods for treating an ischemic disorder and improving stroke outcome
10/07/1999	WO1999049876A2 Bacterial or yeast extracts which stimulate the production of defensins and methods of use thereof
10/07/1999	WO1999049861A1 Deodorant agents for oral use for discharges and method for relieving odor of discharges
10/07/1999	WO1999049855A2 Ipg antagonists for the treatment of conditions involving mast cells, basophils and eosinophils
10/07/1999	WO1999041614A3 Method for detecting intimin producing microorganisms
10/07/1999	WO1999029717A3 Postweaning multisystemic wasting syndrome virus from pigs
10/07/1999	WO1999024077A3 Compositions and methods for targeted delivery of biologically-active factors
10/07/1999	WO1999023221A3 Multivalent antigen-binding proteins
10/07/1999	DE19814925A1 Arzneimittel zur Induktion zytotoxischer T-Zellen Drugs for the induction of cytotoxic T cells
10/07/1999	DE19812941A1 Arzneimittel zur Vermeidung oder Behandlung von Papillomavirusspezifischem Tumor Medicines used to prevent or treat Papillomavirusspezifischem tumor
10/07/1999	DE19812940A1 Formulierung mit Papillomavirus-spezifischem Protein, seine Herstellung und Verwendung Formulation with papillomavirus-specific protein, its preparation and use
10/07/1999	CA2731416A1 Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis
10/07/1999	CA2401916A1 Recombinant anti-tumor rnase
10/07/1999	CA2347067A1 Dendritic cell vaccine containing telomerase reverse transcriptase for the treatment of cancer
10/07/1999	CA2326588A1 Methods for treating an ischemic disorder and improving stroke outcome
10/07/1999	CA2326391A1 Identification of bacterial avirulence genes and their products; vaccines and pharmaceutical compositions containing them
10/07/1999	CA2324864A1 Immune response modulator alpha-2 macroglobulin complex
10/07/1999	CA2324477A1 Use of active p40 conjugates for nasal delivery
10/07/1999	CA2324441A1 Materials and methods relating to a novel retrovirus
10/07/1999	CA2323524A1 Nk cell activation inducing ligand (nail) dna and polypeptides, and use thereof
10/07/1999	CA2321960A1 Treatment and diagnosis of staphylococcal infections
10/07/1999	CA2320491A1 Stimulated monocyte derived cells, their preparation and uses
10/07/1999	CA2319588A1 Materials and methods relating to the treatment of conditions involving mast cells basophils and eosinophils
10/06/1999	EP0947583A2 DNA fragments activated in expression of melanoma inhibiting protein (MIA)
10/06/1999	EP0947491A1 Highly pure squalane, raw material for pharmaceuticals and cosmetics prepared by using the same and method for producing the same
10/06/1999	EP0946880A1 Method for diagnosis and therapy of hodgkin lymphomas
10/06/1999	EP0946731A1 Non-m non-o hiv strains, fragments and applications
10/06/1999	EP0946730A2 Mutants of streptococcal toxin c and methods of use
10/06/1999	EP0946725A2 Receptor activator of nf-kappa b, receptor is member of tnf receptor superfamily
10/06/1999	EP0946714A1 Recombinant equine herpesvirus type 1 (ehv-1) comprising a dysfunctional gene 71 region and use thereof as a vaccine
10/06/1999	EP0946710A1 Methods of preserving prokaryotic cells and compositions obtained thereby
10/06/1999	EP0946624A1 Biodegradable targetable microparticle delivery system
10/06/1999	EP0946592A2 Immuno-reactive peptide ctl epitopes of human cytomegalovirus

1 ... 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 ... 1823